Medtronic plc

NYSE:MDT

Medical - Devices

Healthcare
$100.72 +0.96%

+$0.75 today

Market cap
$128.84B
Beta
0.60
P/E (TTM)
21.1
EPS (TTM)
$3.74
Dividend yield
3.60%
52W Low $73.31High $106.33

Volume 6.47M

Average 11.36M

MDT Gross Profit

Revenue minus cost of revenue: what remains to cover operating expenses after paying for what was sold.

Medtronic plcNYSE: MDT

Gross Profit · Q1 FY2027 · quarter ended Jul 2026

Gross profit growth accelerates

Q1 FY2027 gross profit of $6.34B rose 28.2% year over year, ahead of the +15.4% change in trailing-twelve-month gross profit. Sequentially, it fell 15.9% from the prior quarter. Over 3 fiscal years it compounded at +4.9% a year.

Context

  • Gross profit amounted to 65.0% of revenue in FY2026, down 0.3 pp from a year earlier.
  • Gross profit increased in 3 of the last 3 fiscal years.
  • FY2026 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +28.2% holds above the trailing-twelve-month pace of +15.4%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJul 2026
$6.34B-15.9% QoQ
Last fiscal yearApr 2026
$23.64B+7.9% YoY
LTMJul 2026
$25.04B+15.4% YoY
Gross Profit past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+28.2%——
1 year+7.9%——
3-year CAGR+4.9%——
5-year CAGR——
10-year CAGR——

Gross Profit history

USD · from the income statement

Latest · FY2026
23.64B USD
Year-over-year change
+7.9%
4-year CAGR
+2.4%

Gross Profit vs competitors

How MDT compares with its peers on the latest reported figures

  • Peers report in different currencies, so gross profit is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +15.4% is the 3rd highest of 9, against a peer median of +11.6%.
  • Gross profit amounts to 66.7% of revenue for MDT, versus a peer median of 67.9%.
MDT Competitors
Gross Profit for MDT and competitors
Company Period LTM YoY 3-year CAGR% of revenue
MDTMedtronic plcLTM Jul 2026$25.04B USD+15.4%+4.9%66.7%
SYKStryker CorporationLTM Jun 2026$16.84B USD+12.4%+13.3%65.2%
BSXBoston Scientific CorporationLTM Jun 2026$14.94B USD+27.8%+21.5%71.2%
PHGKoninklijke Philips N.V.LTM Jun 2026€8.11B EUR+3.6%+3.9%45.9%
ZBHZimmer Biomet Holdings, Inc.LTM Jun 2026$5.95B USD+6.8%+1.0%69.9%
EWEdwards Lifesciences CorporationLTM Jun 2026$5.08B USD+13.2%+4.0%78.0%
LIVNLivaNova PLCLTM Sep 2026$1.02B USD+10.7%+9.9%67.9%
PENPenumbra, Inc.LTM Jun 2026$1.02B USD+20.0%+20.8%67.8%
AVRAnteris Technologies Global Corp.LTM Mar 2026$523K USD-60.4%—28.3%
Peer median (excluding MDT) —+11.6%+9.9%67.9%

Competitors are the stored peer set for MDT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Apr 2022
FY2023
Apr 2023
FY2024
Apr 2024
FY2025
Apr 2025
FY2026
Apr 2026
Revenue31.69B31.23B32.36B33.54B36.36B
Cost of Revenue10.15B10.72B11.22B11.63B12.72B
Gross Profit21.54B20.51B21.15B21.91B23.64B
Gross Margin68.0%65.7%65.3%65.3%65.0%
Research & Development2.75B2.7B2.74B2.73B2.87B
Selling, General & Admin10.29B10.42B10.74B10.85B11.78B
Operating Expenses15.79B15.02B16B15.95B17.18B
Depreciation & Amortization2.71B2.7B2.65B2.86B2.96B
EBITDA8.78B8.7B8.2B9.22B9.81B
EBITDA Margin27.7%27.9%25.3%27.5%27.0%
Operating Income5.75B5.49B5.14B5.96B6.47B
Operating Margin18.2%17.6%15.9%17.8%17.8%
Interest Income00000
Interest Expense553M636M719M729M715M
Other Income / Expenses(235M)(121M)(307M)(327M)(331M)
Income Before Tax5.52B5.36B4.84B5.63B6.14B
Pre-Tax Margin17.4%17.2%14.9%16.8%16.9%
Income Tax Expense456M1.58B1.13B936M1.3B
Net Income5.04B3.76B3.68B4.66B4.8B
Net Margin15.9%12.0%11.4%13.9%13.2%
EPS (Basic)3.752.832.773.633.75
EPS (Diluted)3.732.822.763.613.73
Weighted Avg Shares1.34B1.33B1.33B1.29B1.28B
Weighted Avg Shares (Diluted)1.35B1.33B1.33B1.29B1.29B

Medtronic plc

NYSE:MDT

Intrinsic Alpha fair value

Locked

Current Price

$100.72

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.